Matilda Azis

Matilda Azis

Auto-generated profile, based on publicly available information

Matilda Azis

Early Psychosis: Interventions and Clinical-detection (EPIC) lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in JAMA Psychiatry
Verified
Journal Article
Open access
PDF file
SJSameer Jauhar
Sameer Jauhar
MNMatthew M. Nour
Matthew M. Nour
MVMattia Veronese
Mattia Veronese
MRMaria Rogdaki
Maria Rogdaki
IBIlaria Bonoldi
Ilaria Bonoldi
OHOliver D. Howes
Oliver D. Howes
Psychotic illnesses, such as schizophrenia and bipolar affective disorder, have a combined lifetime prevalence of approximately 3%.1 The research domain criteria initiative from the National Institute of Mental Health proposes that common neurobiological mechanisms underlie symptom domains across disorders.2 The neuromodulator dopamine has been implicated in the pathophysiology of psychosis in schizophrenia3-9 and psychosis in other disorders.10 Investigations using positron emission tomography (PET) have demonstrated increased striatal dopamine synthesis capacity in schizophrenia.11 Dopamine synthesis capacity is also elevated in individuals at high clinical risk of psychosis,12-16 some of whom may develop bipolar affective disorder with psychosis,17 and in individuals with psychosis in the context of temporal lobe epilepsy.10 These findings suggest that elevated dopamine synthesis capacity may be transdiagnostic, underlying psychosis across disorders, rather than specific to schizophrenia. Evidence also suggests that dopamine dysfunction increases with development of psychosis15 and is greater in acute psychosis relative to remission,9 suggesting a state component.

24 October 2018 in Schizophrenia Bulletin
Verified
Journal Article
Closed access
TVTeresa Vargas
Teresa Vargas
PLPhoebe H Lam
Phoebe H Lam
MAMatilda Azis
Matilda Azis
KOK Juston Osborne
K Juston Osborne
ALAmy Lieberman
Amy Lieberman
VMVijay A Mittal
Vijay A Mittal
Background: Characterizing the link between childhood trauma and adult neurocognitive function in psychosis is crucial for improving the fields understanding of how early environmental risk factors impact the presentation of the disorder. To date, the literature has been inconsistent: meta-analytic synthesis is lacking, and it is unclear whether specific cognitive functions are affected. Methods: A meta-analysis was performed on a total of 3315 subjects with a psychotic disorder. The links between childhood trauma, overall neurocognitive function, and four cognitive subdomains (working memory, executive function, verbal/visual memory, and attention/processing speed) were examined. Relevant sample characteristics and methodological moderators were tested. The strength of the association between trauma and overall neurocognition in individuals with psychotic disorders was also compared to that of healthy controls. Results: Among individuals with psychotic disorders, there was a significant association between overall cognition and childhood trauma, r = −.055; 95% CI = −0.09, −0.02, P = .002. There was also a modest, negative relationship between childhood trauma and working memory, r = −.091; 95% CI = −0.15, −0.03, P = .002. Moderators did not have a significant effect on these analyses. Further, the association between childhood trauma and neurocognition was significantly stronger in healthy controls compared to patients with a psychotic disorder. Conclusion: A small negative association was found between overall cognition and childhood trauma in individuals with psychotic disorders. Results suggest the association is less strong for individuals with a psychotic disorder compared to healthy populations. Findings are informative for prominent etiological models of psychosis.

3 May 2021 in Neuropsychopharmacology
Verified
Journal Article
Open access
PDF file
GMGemma Modinos
Gemma Modinos
ARAnja Richter
Anja Richter
AEAlice Egerton
Alice Egerton
IBIlaria Bonoldi
Ilaria Bonoldi
MAMatilda Azis
Matilda Azis
PMPhilip McGuire
Philip McGuire
Preclinical models propose that increased hippocampal activity drives subcortical dopaminergic dysfunction and leads to psychosis-like symptoms and behaviors. Here, we used multimodal neuroimaging to examine the relationship between hippocampal regional cerebral blood flow (rCBF) and striatal dopamine synthesis capacity in people at clinical high risk (CHR) for psychosis and investigated its association with subsequent clinical and functional outcomes. Ninety-five participants (67 CHR and 28 healthy controls) underwent arterial spin labeling MRI and 18F-DOPA PET imaging at baseline. CHR participants were followed up for a median of 15 months to determine functional outcomes with the global assessment of function (GAF) scale and clinical outcomes using the comprehensive assessment of at-risk mental states (CAARMS). CHR participants with poor functional outcomes (follow-up GAF < 65, n = 25) showed higher rCBF in the right hippocampus compared to CHRs with good functional outcomes (GAF ≥ 65, n = 25) (pfwe = 0.026). The relationship between rCBF in this right hippocampal region and striatal dopamine synthesis capacity was also significantly different between groups (pfwe = 0.035); the association was negative in CHR with poor outcomes (pfwe = 0.012), but non-significant in CHR with good outcomes. Furthermore, the correlation between right hippocampal rCBF and striatal dopamine function predicted a longitudinal increase in the severity of positive psychotic symptoms within the total CHR group (p = 0.041). There were no differences in rCBF, dopamine, or their associations in the total CHR group relative to controls. These findings indicate that altered interactions between the hippocampus and the subcortical dopamine system are implicated in the pathophysiology of adverse outcomes in the CHR state.

19 August 2017 in International Journal of Neuropsychopharmacology
Verified
Journal Article
Open access
PDF file
GMGemma Modinos
Gemma Modinos
FŞFatma Şimşek
Fatma Şimşek
JHJamie Horder
Jamie Horder
MBMatthijs Bossong
Matthijs Bossong
IBIlaria Bonoldi
Ilaria Bonoldi
PMPhilip McGuire
Philip McGuire
Whilst robust preclinical and postmortem evidence suggests that altered GABAergic function is central to the development of psychosis, little is known about whether it is altered in subjects at ultra-high risk of psychosis, or its relationship to prodromal symptoms. Twenty-one antipsychotic naïve ultra-high risk individuals and 20 healthy volunteers underwent proton magnetic resonance imaging at 3T. Gamma-aminobutyric acid levels were obtained from the medial prefrontal cortex using MEGA-PRESS and expressed as peak-area ratios relative to the synchronously acquired creatine signal. Gamma-aminobutyric acid levels were then related to severity of positive and negative symptoms as measured with the Community Assessment of At-Risk Mental States. Whilst we found no significant difference in gamma-aminobutyric acid levels between ultra-high risk subjects and healthy controls (P=.130), in ultra-high risk individuals, medial prefrontal cortex GABA levels were negatively correlated with the severity of negative symptoms (P=.013). These findings suggest that gamma-aminobutyric acidergic neurotransmission may be involved in the neurobiology of negative symptoms in the ultra-high risk state.

18 September 2019 in Schizophrenia Bulletin
Verified
Journal Article
Open access
PDF file
GMGemma Modinos
Gemma Modinos
PAPaul Allen
Paul Allen
AZAndre Zugman
Andre Zugman
DDDanai Dima
Danai Dima
MAMatilda Azis
Matilda Azis
PMPhilip McGuire
Philip McGuire
Psychosis has been proposed to develop from dysfunction in a hippocampal-striatal-midbrain circuit, leading to aberrant salience processing. Here, we used functional magnetic resonance imaging (fMRI) during novelty salience processing to investigate this model in people at clinical high risk (CHR) for psychosis according to their subsequent clinical outcomes. Seventy-six CHR participants as defined using the Comprehensive Assessment of At-Risk Mental States (CAARMS) and 31 healthy controls (HC) were studied while performing a novelty salience fMRI task that engaged an a priori hippocampal-striatal-midbrain circuit of interest. The CHR sample was then followed clinically for a mean of 59.7 months (~5 y), when clinical outcomes were assessed in terms of transition (CHR-T) or non-transition (CHR-NT) to psychosis (CAARMS criteria): during this period, 13 individuals (17%) developed a psychotic disorder (CHR-T) and 63 did not. Functional activation and effective connectivity within a hippocampal-striatal-midbrain circuit were compared between groups. In CHR individuals compared to HC, hippocampal response to novel stimuli was significantly attenuated (P = .041 family-wise error corrected). Dynamic Causal Modelling revealed that stimulus novelty modulated effective connectivity from the hippocampus to the striatum, and from the midbrain to the hippocampus, significantly more in CHR participants than in HC. Conversely, stimulus novelty modulated connectivity from the midbrain to the striatum significantly less in CHR participants than in HC, and less in CHR participants who subsequently developed psychosis than in CHR individuals who did not become psychotic. Our findings are consistent with preclinical evidence implicating hippocampal-striatal-midbrain circuit dysfunction in altered salience processing and the onset of psychosis.

1 April 2016 in Comprehensive Psychiatry
Verified
Journal Article
Closed access
LMLuis Madeira
Luis Madeira
IBIlaria Bonoldi
Ilaria Bonoldi
MRMatteo Rocchetti
Matteo Rocchetti
CSCarly Samson
Carly Samson
MAMatilda Azis
Matilda Azis
GSGiovanni Stanghellini
Giovanni Stanghellini